Suchergebnisse - "Schmid, Peter"

PubPharm (633)

41

Emerging strategies for TNBC with early clinical data: new chemoimmunotherapy strategies

enthalten in: Breast cancer research and treatment | 2022

von Hall, P. | Schmid, P.

42

Immunotherapy for early triple negative breast cancer : research agenda for the next decade

enthalten in: NPJ breast cancer | 2022

von Tarantino, P. | Corti, C. | Schmid, P. | +7

43

Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer

enthalten in: The New England journal of medicine | 2022

von Schmid, P. | Cortes, J. | Dent, R. | +128

CommentIn: Nat Rev Clin Oncol. 2022 Apr;19(4):220. - PMID 35217781

44

Nickel release from metal items in contact with skin : a comparison of methods and practical implications for regulation in Europe

enthalten in: Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering | 2022

von Blaser, P. | Rothmund, B. | Schmid, P. | +3

45

Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer

enthalten in: Journal of clinical oncology | [2022]

von Rugo, H. | Bardia, A. | Marmé, F. | +13

46

The use of immunotherapy in triple-negative breast cancer

enthalten in: Clinical advances in hematology & oncology : H&O | 2021

von Schmid, P.

47

Fulvestrant-Palbociclib vs Letrozole-Palbociclib as Initial Therapy for Endocrine-Sensitive, Hormone Receptor-Positive, ERBB2-Negative Advanced Breast Cancer : A Randomized Clinical Trial

enthalten in: JAMA oncology | 2021

von Llombart-Cussac, A. | Pérez-García, J. | Bellet, M. | +52

ErratumIn: JAMA Oncol. 2021 Nov 1;7(11):1729. - PMID 34792545

48

PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel-Treated Advanced Triple-Negative Breast Cancer

enthalten in: Journal of the National Cancer Institute | 2021

von Rugo, H. | Loi, S. | Adams, S. | +14

CommentIn: J Natl Cancer Inst. 2021 Nov 29;113(12):1613-1614. - PMID 34097056

49

New fossils of Australopithecus sediba reveal a nearly complete lower back

enthalten in: eLife | 2021

von Williams, S. | Prang, T. | Meyer, M. | +14

50

Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer : Biomarker Evaluation of the IMpassion130 Study

enthalten in: Journal of the National Cancer Institute | 2021

von Emens, L. | Molinero, L. | Loi, S. | +12